StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.21−0.41 (-6.19%)

Close on Nov 18, 2026Market cap $374.43MP/E –Yield –

Eupraxia Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Eupraxia Pharmaceuticals figures

See a number that looks wrong?